Kathy P. Ordonez's most recent trade in Pacific Biosciences of California Inc was a trade of 65,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 32,179 | 32,179 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 22,821 | 403,037 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 324,515 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 15 Mar 2024 | 324,515 | 343,110 (0%) | 0% | 2.9 | 941,094 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 37,106 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 15 Mar 2024 | 37,106 | 380,216 (0%) | 0% | 2.6 | 97,589 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 16 Feb 2022 | 3,280 | 18,595 (0%) | 0% | 11.5 | 37,720 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,885 | 12,885 | - | - | Stock Option (right to buy) | |
| QuidelOrtho Corporation | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,624 | 1,624 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 427 | 427 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 42 | 42 | - | - | Restricted Stock Units (Premium) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Sale of securities on an exchange or to another person at price $ 47.58 per share. | 16 Feb 2021 | 118,667 | 123,979 (0%) | 0% | 47.6 | 5,646,651 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Sale of securities on an exchange or to another person at price $ 48.47 per share. | 16 Feb 2021 | 101,004 | 22,975 (0%) | 0% | 48.5 | 4,895,260 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 50,394 | 37,106 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 16 Feb 2021 | 50,394 | 242,646 (0%) | 0% | 2.6 | 132,536 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.98 per share. | 16 Feb 2021 | 35,000 | 91,767 (0%) | 0% | 7.0 | 244,300 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 16 Feb 2021 | 25,485 | 192,252 (0%) | 0% | 2.9 | 73,907 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 25,485 | 324,515 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.81 per share. | 16 Feb 2021 | 25,000 | 166,767 (0%) | 0% | 3.8 | 95,250 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.98 per share. | 16 Feb 2021 | 25,000 | 141,767 (0%) | 0% | 9.0 | 224,500 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.79 per share. | 16 Feb 2021 | 25,000 | 116,767 (0%) | 0% | 5.8 | 144,750 | Common Stock |
| Pacific Biosciences of Cal... | Kathy P. Ordonez | Director | Sale of securities on an exchange or to another person at price $ 49.00 per share. | 16 Feb 2021 | 1,100 | 21,875 (0%) | 0% | 49 | 53,900 | Common Stock |